Amy Backus, NP
Family · Little Rock, ARNPI 1851737787
Payments from drug & device makers
Across 124 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$293
- AbbVie$274
- Pfizer$234
- Lilly USA, LLC$170
- Novo Nordisk$139
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$138
- plus $616 from 19 others
What the payments were for
- Food & beverage$1,865100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $293 |
| AbbVie | 16 | $274 |
| Pfizer | 18 | $234 |
| Lilly USA, LLC | 13 | $170 |
| Novo Nordisk | 10 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $138 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $77 |
| Genentech USA, Inc. | 8 | $71 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Exact Sciences | 3 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Johnson & Johnson | 2 | $42 |
| Amgen | 2 | $35 |
| Lundbeck LLC | 2 | $29 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Biogen | 1 | $21 |
| Novartis | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 7 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| GSK | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Bayer | 1 | $14 |
How this compares
$1,865 in reported general payments places this provider in the 80th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omega-3 Acid Ethyl Esters | 15 | $552 |
| Gabapentin | 21 | $250 |
| Lisinopril | 43 | $159 |
| Topiramate | 14 | $149 |
| Metformin Hcl | 51 | $128 |
| Omeprazole | 15 | $95 |
| Metoprolol Tartrate | 12 | $69 |
| Atorvastatin Calcium | 27 | $69 |
| Pantoprazole Sodium | 24 | $62 |
| Amlodipine Besylate | 49 | $60 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $37 |
| Hydrochlorothiazide | 21 | $30 |
Paid to pharmacies, not to this prescriber.
Other family in Little Rock
- Anthony EcholsLittle Rock$25K
- Michael StirlingLittle Rock$23K
- Laura BarganierLittle Rock$17K
- Emily AllenLittle Rock$14K
- Brandy EasonLittle Rock$13K
- Matthew TaylorLittle Rock$10K
- Collene RogersLittle Rock$9K
- Morgan BittengleLittle Rock$9K
- Melissa BaldwinLittle Rock$8K
- Leah CarringtonRogers$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.